172 related articles for article (PubMed ID: 17875892)
1. A novel PTPN11 gene mutation in a patient with LEOPARD Syndrome.
Du-Thanh A; Cave H; Bessis D; Puso C; Guilhou JJ; Dereure O
Arch Dermatol; 2007 Sep; 143(9):1210-1. PubMed ID: 17875892
[No Abstract] [Full Text] [Related]
2. [Noonan syndrome and Leopard syndrome linked to mutation of the gene PTPN11].
Dereure O
Ann Dermatol Venereol; 2005 Apr; 132(4):400. PubMed ID: 15886577
[No Abstract] [Full Text] [Related]
3. A novel PTPN11 mutation in LEOPARD syndrome.
Conti E; Dottorini T; Sarkozy A; Tiller GE; Esposito G; Pizzuti A; Dallapiccola B
Hum Mutat; 2003 Jun; 21(6):654. PubMed ID: 14961557
[TBL] [Abstract][Full Text] [Related]
4. Familial aggregation of genetically heterogeneous hypertrophic cardiomyopathy: a boy with LEOPARD syndrome due to PTPN11 mutation and his nonsyndromic father lacking PTPN11 mutations.
Digilio MC; Pacileo G; Sarkozy A; Limongelli G; Conti E; Cerrato F; Marino B; Pizzuti A; Calabrò R; Dallapiccola B
Birth Defects Res A Clin Mol Teratol; 2004 Feb; 70(2):95-8. PubMed ID: 14991917
[TBL] [Abstract][Full Text] [Related]
5. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.
Bentires-Alj M; Paez JG; David FS; Keilhack H; Halmos B; Naoki K; Maris JM; Richardson A; Bardelli A; Sugarbaker DJ; Richards WG; Du J; Girard L; Minna JD; Loh ML; Fisher DE; Velculescu VE; Vogelstein B; Meyerson M; Sellers WR; Neel BG
Cancer Res; 2004 Dec; 64(24):8816-20. PubMed ID: 15604238
[TBL] [Abstract][Full Text] [Related]
6. [PTPN11 gene mutation in LEOPARD syndrome].
Paradisi M; Pedicelli C; Ciasulli A; Pinto F; Conti E; Sarkozy A; Angelo C
Minerva Pediatr; 2005 Aug; 57(4):189-93. PubMed ID: 16172598
[TBL] [Abstract][Full Text] [Related]
7. PTPN11 mutations in patients with LEOPARD syndrome: a French multicentric experience.
Keren B; Hadchouel A; Saba S; Sznajer Y; Bonneau D; Leheup B; Boute O; Gaillard D; Lacombe D; Layet V; Marlin S; Mortier G; Toutain A; Beylot C; Baumann C; Verloes A; Cavé H;
J Med Genet; 2004 Nov; 41(11):e117. PubMed ID: 15520399
[No Abstract] [Full Text] [Related]
8. PTPN11 mutations and genotype-phenotype correlations in Noonan and LEOPARD syndromes.
Ogata T; Yoshida R
Pediatr Endocrinol Rev; 2005 Jun; 2(4):669-74. PubMed ID: 16208280
[TBL] [Abstract][Full Text] [Related]
9. Acute myelomonocytic leukemia in a boy with LEOPARD syndrome (PTPN11 gene mutation positive).
Uçar C; Calýskan U; Martini S; Heinritz W
J Pediatr Hematol Oncol; 2006 Mar; 28(3):123-5. PubMed ID: 16679933
[TBL] [Abstract][Full Text] [Related]
10. Two novel and one recurrent PTPN11 mutations in LEOPARD syndrome.
Yoshida R; Nagai T; Hasegawa T; Kinoshita E; Tanaka T; Ogata T
Am J Med Genet A; 2004 Nov; 130A(4):432-4. PubMed ID: 15389709
[No Abstract] [Full Text] [Related]
11. PTPN11 mutations in Noonan syndrome type I: detection of recurrent mutations in exons 3 and 13.
Maheshwari M; Belmont J; Fernbach S; Ho T; Molinari L; Yakub I; Yu F; Combes A; Towbin J; Craigen WJ; Gibbs R
Hum Mutat; 2002 Oct; 20(4):298-304. PubMed ID: 12325025
[TBL] [Abstract][Full Text] [Related]
12. Genotype-phenotype correlations in Noonan syndrome.
Zenker M; Buheitel G; Rauch R; Koenig R; Bosse K; Kress W; Tietze HU; Doerr HG; Hofbeck M; Singer H; Reis A; Rauch A
J Pediatr; 2004 Mar; 144(3):368-74. PubMed ID: 15001945
[TBL] [Abstract][Full Text] [Related]
13. Novel mitochondrial DNA mutations implicated in Noonan syndrome.
Dhandapany PS; Sadayappan S; Vanniarajan A; Karthikeyan B; Nagaraj C; Gowrishankar K; Selvam GS; Singh L; Thangaraj K
Int J Cardiol; 2007 Aug; 120(2):284-5. PubMed ID: 17092585
[TBL] [Abstract][Full Text] [Related]
14. [LEOPARD syndrome].
Yoshida R
Nihon Rinsho; 2006 Sep; Suppl 3():465-7. PubMed ID: 17022588
[No Abstract] [Full Text] [Related]
15. A novel PTPN11 missense mutation in a patient with LEOPARD syndrome.
Osawa R; Akiyama M; Yamanaka Y; Ujiie H; Nemoto-Hasebe I; Takeda A; Yanagi T; Shimizu H
Br J Dermatol; 2009 Nov; 161(5):1202-4. PubMed ID: 19659470
[No Abstract] [Full Text] [Related]
16. [Clinical symptoms and molecular pathogenesis of Noonan syndrome--current concepts].
Klapecki J; Obersztyn E; Laniewski-Wollk M; Szpecht-Potocka A; Mazurczak T
Med Wieku Rozwoj; 2006; 10(1 Pt 2):289-308. PubMed ID: 17028394
[TBL] [Abstract][Full Text] [Related]
17. Acute myeloid leukemia in an adult Noonan syndrome patient with PTPN11 mutation.
Matsubara K; Yabe H; Ogata T; Yoshida R; Fukaya T
Am J Hematol; 2005 Jun; 79(2):171-2. PubMed ID: 15929108
[No Abstract] [Full Text] [Related]
18. Genetics and variation in phenotype in Noonan syndrome.
Jongmans M; Otten B; Noordam K; van der Burgt I
Horm Res; 2004; 62 Suppl 3():56-9. PubMed ID: 15539800
[TBL] [Abstract][Full Text] [Related]
19. BIAcore analysis to test phosphopeptide-SH2 domain interactions.
Vély F; Trautmann A; Vivier E
Methods Mol Biol; 2000; 121():313-21. PubMed ID: 10818737
[No Abstract] [Full Text] [Related]
20. Noonan syndrome type I with PTPN11 3 bp deletion: structure-function implications.
Lee WH; Raas-Rotschild A; Miteva MA; Bolasco G; Rein A; Gillis D; Vidaud D; Vidaud M; Villoutreix BO; Parfait B
Proteins; 2005 Jan; 58(1):7-13. PubMed ID: 15521065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
